Predictors of Mucosal Healing in Inflammatory Bowel Disease (IBD) Patients Treated With Anti-TNF

NCT01605175 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2015-11-17

No results posted yet for this study

Summary

The aim of this study is to prospectively identify, at diagnosis of the disease, factors predictive of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF.

Conditions

Sponsors & Collaborators

  • University of Athens

    collaborator OTHER
  • Laikο General Hospital, Athens

    collaborator OTHER
  • Evangelismos Hospital

    lead OTHER

Principal Investigators

  • Nikos Viazis, Director · Evangelismos Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01605175 on ClinicalTrials.gov